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background:  Myocarditis is a major cause of heart failure and arrhythmia. This study evaluated whether a small heat shock protein, alpha 
B-crystallin (CryAB), could suppress arrhythmia in experimental autommune myocarditis (EAM) rats.
Methods:  Porcine cardiac myosin (1 mg) was injected into footpads of adult Sprague-Dawley rats on day 1 and 8 (EAM, n=10). In 14 EAM 
rats, CryAB (1mg/kg) with TAT-protein transduction domain (EAM+CryAB, n=8) or GFP (EAM+G, n=6) were injected via intraperitoneum 
for 2 weeks. Hearts were perfused, mapped optically to analyze action potential durations (APD), and restitution kinetics, and tested for VF 
vulnerability. The intracellular calcium dynamics were measured in rat neonatal cardiomyocyte treated with TNF- (10 ng/ml) for 1 hours.
results:  In EAM groups, 4(40%) rats died and had ventricular arrhythmia. However, no rat died and had arrhythmia in Myo+CryAB group 
(p=0.04). EAM hearts had enlarged left ventricle, longer APD90, slower conduction velocity (CV; P<0.01 versus control) and higher levels 
of transcripts for Cox2, iNOS, TNF-α, IL-6, HMGB1 (P<0.05 versus control). CryAB treatment reversed the transcripts for inflammation, 
ventricular enlargement (P<0.05), APD90 and CV (P<0.01). Programmed stimulation triggered VF in EAM (n=4/10) and EAM+G (n=2/6), 
but not in control (n=0/10) and EAM+CryAB (n=1/8; P<0.01). Compared with control, rat neonatal cardiomyocyte treated with TNF- 
showed increased Ca2+ wave frequency (1.0±0.0 vs. 4.2±0.2, p=0.001) and Ca2+ Amplitude (1.0±0.0 vs. 3.1±0.1 AU, p=0.001). However, 
the increased Ca2+ release was suppressed by CryAB treatment. Finally, CaMKII autophosphorylation at Thr287 (201%), and RyR2 
phosphorylation at Ser2808 (protein kinase A/CaMKII site, 126%) and Ser2814 (CaMKII site, 21%) were increased in myocarditis and 
reversed by CryAB.
Conclusion:  CryAB treatment suppressed ventricular arrhythmia in EAM heats by preventing spontaneous Ca2+ release, and attenuating 
inflammation and oxidative stress. This study provides compelling evidence that CryAB may provide a novel therapy to manage myocarditis 
by reversing inflammation and oxidative stress.
